Anaptys Announces Participation in November and December Investor Conferences - AnaptysBio ( NASDAQ:ANAB )

a week ago

SAN DIEGO, Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ANAB, a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its senior management ...

Ticker	Sentiment	Impact
ANAB	Somewhat Bullish	21 %